In this eBook, we rethink the well-known challenges in infectious disease (ID) research by providing innovative solutions to patient reach, recruitment, retention, and biospecimen collection. You’ll learn how Sanguine’s patient-led approach and operational experience has been instrumental in meeting the high demands of COVID-19-related clinical research. We were perfectly poised to recruit study participants and collect biospecimens and data through our mobile workforce across the United States.
Introduction:
The COVID-19 pandemic has thrust the importance of infectious disease research into the forefront of the minds of the general public. It has never been more evident that there is a desperate need for therapeutics and vaccines to fight emerging threats prior to global devastation as seen due to COVID-19. Infectious disease pressure on public health has intensified in recent years due to many factors, including climate change, globalization, destruction of wildlife habitats causing zoonotic transfer, and increasing resistance to antimicrobial agents.(3)
We are constantly facing the threat of re-emerging pathogens, such as influenza or measles and the appearance of new threats, such as novel coronaviruses or antibiotic-resistant bacteria.